Life Science Executive Partnering
Monday 16 November 2026London, UK James FieldCEO at LabGenius TherapeuticsSpeaker
Profile
James, a protein engineer by training, founded LabGenius Therapeutics during his PhD studies at Imperial College London. In pursuit of LabGenius’ mission to advance the next generation of complex therapeutic antibodies, James has raised >$75M from top-tier VCs, inked R&D partnerships with leading pharma companies and overseen the development of maturation of LabGenius’ ML-driven protein engineering platform (EVA™).
Agenda Sessions
Where Has AI Been Most Effective in Life Sciences? Lessons Learned and the Path Forward
, 14:00View Session